Evidence map›Paper›PMID 31063991›Full record

ArticleThe Journal of clinical investigation2019

Trim the gut, lose the weight - and the bone.

Soravis Osataphan, Mary Elizabeth Patti

Open access · bronzeAbstract readComment
In one paragraph

Article in The Journal of clinical investigation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Trial
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Soravis Osataphan
Mary Elizabeth Patti
Harvard University · US

Funding

SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI ROHIT N. KULKARNI · 1986 to 2026
$50.5M
Alliance of Randomized Trials of Medicine vs Metabolic Surgery in Type 2 Diabetes - (ARMMS-T2D)U01DK114156 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · PI AMINIAN, ALI, KIRWAN, JOHN P. · 2017 to 2022
$8.9M
Paternal Contributions to Metabolic Disease in Offspring: Environment, Epigenetics, and SpermR01DK106193 · NIDDK · JOSLIN DIABETES CENTER · PI PATTI, MARY E · 2016 to 2024
$4.3M
Impact of Metabolic Health in Type 2 Diabetes on Sperm Epigenetic Marks in Humans: A Novel Intergenerational Mechanism for Metabolic Disease Risk TransmissionR21HD091974 · NICHD · JOSLIN DIABETES CENTER · PI ISGANAITIS, ELVIRA MARIE, PATTI, MARY E · 2018 to 2019
$462k
NICHD NIH HHS R21 HD091974NIDDK NIH HHS P30 DK036836NIDDK NIH HHS R01 DK106193NIDDK NIH HHS U01 DK114156
6 · The paper itself

Abstract

Vertical sleeve gastrectomy (VSG) is an effective therapeutic approach for obesity and type 2 diabetes but is associated with osteoporosis. In this issue of the JCI, Li et al. report that VSG rapidly reduces bone mass, as observed in humans, via rapid demineralization and decreased bone formation, independent of weight loss or Ca2+/vitamin D deficiency. VSG also reduces bone marrow adipose tissue, in part via increased granulocyte-colony stimulating factor (G-CSF). The interplay between VSG-mediated effects on systemic metabolism and bone biology remain to be investigated. These findings suggest novel mechanisms and therapeutic targets for bariatric surgery-induced osteoporosis.

Indexed as

Diabetes Mellitus, Type 2Gastrointestinal MicrobiomeBone MarrowGastrectomyGranulocyte Colony-Stimulating FactorHumansGranulocyte Colony-Stimulating Factor

Identifiers

PMID31063991
PMCPMC6546462
OpenAlexW2943769439

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.